Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-28

Clinical Trial Update: Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials

View source ↗

Summary

A retrospective safety survey evaluated outcomes in patients who participated in NV1FGF clinical trials for Peripheral Arterial Occlusive Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NV1FGF (NV1FGF)

Snippet

Sponsor: Sanofi | Conditions: Peripheral Arterial Occlusive Disease | Status: COMPLETED